ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 29 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $236,000 | -75.9% | 1,019,288 | -38.3% | 11.87% | +15728.0% |
| Q4 2021 | $978,000 | -67.5% | 1,651,357 | -50.4% | 0.08% | -68.8% |
| Q3 2021 | $3,005,000 | -30.6% | 3,330,373 | 0.0% | 0.24% | -39.8% |
| Q2 2021 | $4,329,000 | -6.5% | 3,330,373 | 0.0% | 0.40% | +7.5% |
| Q1 2021 | $4,629,000 | +8.6% | 3,330,373 | 0.0% | 0.37% | +13.1% |
| Q4 2020 | $4,263,000 | -13.5% | 3,330,373 | 0.0% | 0.33% | -26.0% |
| Q3 2020 | $4,929,000 | -6.3% | 3,330,373 | 0.0% | 0.44% | -4.1% |
| Q2 2020 | $5,262,000 | +64.2% | 3,330,373 | 0.0% | 0.46% | +27.3% |
| Q1 2020 | $3,205,000 | -64.7% | 3,330,373 | 0.0% | 0.36% | -76.2% |
| Q4 2019 | $9,092,000 | -30.7% | 3,330,373 | 0.0% | 1.52% | -62.8% |
| Q3 2019 | $13,122,000 | -3.2% | 3,330,373 | 0.0% | 4.10% | +18.1% |
| Q2 2019 | $13,555,000 | -42.0% | 3,330,373 | 0.0% | 3.47% | -38.3% |
| Q1 2019 | $23,379,000 | +28.8% | 3,330,373 | 0.0% | 5.63% | +20.2% |
| Q4 2018 | $18,151,000 | -49.3% | 3,330,373 | 0.0% | 4.68% | -28.5% |
| Q3 2018 | $35,768,000 | -17.6% | 3,330,373 | 0.0% | 6.55% | -27.1% |
| Q2 2018 | $43,395,000 | +18.2% | 3,330,373 | 0.0% | 8.99% | +47.6% |
| Q1 2018 | $36,701,000 | +9.5% | 3,330,373 | 0.0% | 6.09% | +12.1% |
| Q4 2017 | $33,504,000 | – | 3,330,373 | – | 5.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |